Addressing Cardiovascular Risk and Intervening Early
Join us for a free, live webinar as experts dive into the current state of cardiovascular disease in the US, traditional and emerging risk factors, and the critical role of prevention.
BPCI Advanced Reduced Outpatient Spine Surgery Spending
Ensuring Coverage of Faster Biomarker Testing in Lung Cancer: Robert Kratzke, MD
Contributor: Maternal Health Outcomes Are a Systemic Signal
Guselkumab Clears Scalp Psoriasis Across All Skin Tones
Health Equity & Access Weekly Roundup: July 14, 2025
5 Things That Widen Racial Disparities in Childhood Obesity
Trump’s Global Health Pullback Creates Leadership Opportunity for Europe
Patients With Advanced NSCLC Face Critical Treatment Gaps
Child and Adolescent Obesity Exacerbated During the COVID-19 Pandemic
Use of Depression Services Differed by Demographics in People Living With HIV
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Navigating First-Line Therapy Guidelines and Treatment Considerations in High-Risk Cytogenetics
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Aligning Evidence With Access: Disability Outcomes, Data, and Payer Decision-Making
.png%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75)
Closing Perspectives
Evolving Treatment Strategies in Transplant-Ineligible NDMM: Expert Insights From CEPHEUS, IMROZ and BENEFIT
Place in Therapy for Oral Combinations in Relapsed/Refractory AML
From IV to Oral: Reshaping AML Treatment Access and Disease Burden
MD Treatment From a Managed Care Perspective
Child and Adolescent Obesity Exacerbated During the COVID-19 Pandemic
Delays in Detection and the Impact on Access to Targeted Therapy
Analysis Supports Flexible Axatilimab Use in Chronic GVHD, Calls for Combination Therapy Research: Carrie Kitko, MD
Post Hoc Analysis Supports Axatilimab in Heavily Pretreated Patients With Chronic GVHD: Carrie Kitko, MD
Early SYRUS Data Highlight Safety, Efficacy of AZD0486 in Relapsed/Refractory B-Cell ALL: Ibrahim Aldoss, MD
PROs Affirm Zongertinib’s Combination of Strong Response Rates With Low Toxicity
Potential Health Literacy Resources for Health Plans: A Narrative Review
Population Health Reimagined Through Integrated Care
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
Optimizing Advanced Cancer Therapies and Addressing Logistical, Financial Challenges
Value-Based Care Calls for Putting Novel Therapies Closer to Patients
Will Subcutaneous PD-1/PD-L1 Inhibitors Be a Game Changer?
How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid
Utilization and Costs Among Oncologists Participating in a Private Insurance Shared Savings Model
Challenges Faced by Medicaid Managed Care Coordinators Working With Members With Substance Use Disorder
Affordable Care Act Enrollment in Texas After Rating Area Adjustments
Advancing Patient Outcomes in Hidradenitis Suppurativa: Updates and Strategies for Managed Care
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)
From Treatment to Prevention: Navigating the Expanding Hereditary Angioedema Treatment Landscape
Optimizing Outcomes in Myasthenia Gravis: Therapeutic Advances and Value-Based Care Models
Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape
An American Journal of Managed Care® Forum: Discussing the Expanding Targeted Therapy Options and Complexities in Metastatic HER2+ Breast Cancer Treatment
